Ir a las Transacciones
Salud | TMT

Bayer AG has entered into a takeover agreement with Cara Care

December 2024 — Bayer AG, renowned for its advancements in healthcare and life sciences, has finalized the acquisition of Cara Care (HiDoc Technologies GmbH), which entered debtor-in-possession proceedings in October 2024. Cara Care, an innovative digital health platform and official DiGA, aligns perfectly with Bayer’s strategic focus on digital health and the expansion of its innovative solutions portfolio. The transaction is expected to close in Spring 2025.

Cara Care is a digital digestive health solution from Germany that combines both mental and nutritional therapy options. Its MDR Class I-approved treatment for irritable bowel syndrome (IBS) is fully reimbursed by all German statutory health insurance (SHI) and DiGA-certified providers. DiGA refers to digital health applications that are approved for use in Germany and are eligible for reimbursement under the country’s SHI system. The company is a pioneer in the field and is driving growth in an underserved sector. Cara Care has built a product pipeline that addresses not only IBS but also heartburn, dyspepsia and inflammatory bowel disease (IBD).

Bayer AG is a global enterprise with core competencies in the life sciences fields of healthcare and agriculture. Founded in 1863 and headquartered in Leverkusen, Germany, Bayer is known for its innovation-driven approach to improving quality of life. The company operates across three main divisions: pharmaceuticals, consumer health and crop science, delivering products and solutions that address some of the world’s most pressing challenges, particularly in health and food security.

Our role in the transaction

Oaklins’ team in Germany provided comprehensive advisory services to the insolvency administrator and Cara Care in this transaction.

Partes

Contáctese con el equipo de la transacción

Jan P. Hatje

Socio Director
Hamburg, Alemania
Oaklins Germany

Kevin Kambach

Asociado Senior
Hamburg, Alemania
Oaklins Germany

Transacciones relacionadas

Life & Mobility has attracted investor Bolster Investment Partners
Private Equity | Salud

Life & Mobility has attracted investor Bolster Investment Partners

Life & Mobility, a leading developer and manufacturer of premium mobility and rehabilitation solutions, has welcomed Bolster Investment Partners as a new shareholder. The partnership provides Life & Mobility with a strong long-term partner to support the company’s next phase of growth, with a continued focus on product innovation, strengthening its leading market position and further international expansion. The company’s mission remains to enhance the mobility, independence and quality of life of end users through innovative, sustainable and circular mobility solutions designed for multiple life cycles.  

Aprenda más
DIGMATIX has entered Romania through the acquisition of Elian Solutions
Private Equity | TMT

DIGMATIX has entered Romania through the acquisition of Elian Solutions

DIGMATIX, one of the largest providers of Microsoft Business Applications solutions in the region, has acquired Elian Solutions, a Romanian Microsoft Dynamics 365 partner, together with its subsidiary Elian Development Systems. Through the acquisition, DIGMATIX expands its operations into Romania and strengthens its position as a regional leader in the implementation and development of Microsoft Business Applications solutions. The acquisition was financed by an investment from DIGMATIX’s majority shareholder, Baltic private equity fund Livonia Partners, together with financing provided by SEB Bank.

Aprenda más
Heka Dental has joined forces with Impilo to anchor focused buy-and-build strategy
Private Equity | Salud

Heka Dental has joined forces with Impilo to anchor focused buy-and-build strategy

Heka Dental, a leading Danish designer and manufacturer of premium dental treatment units, has been acquired by the Swedish private equity firm Impilo. The acquisition establishes Heka Dental as a strategic platform for consolidation in the European dental equipment market. Impilo will execute a focused buy-and-build strategy to accelerate growth and expand its footprint across Europe.

Aprenda más